ATLAS fair value
£1.35
Below fair value · 13% discount
Target Healthcare REIT share price today, ATLAS forecast and fair value
Real Estate · REIT - Healthcare Facilities · London Stock Exchange · United Kingdom
Prices as of Oct 27, 2026 · GBP
£1.35
Below fair value · 13% discount
54%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Target Healthcare REIT's fair value at about £1.35 per share (reasonable range: £0.763 to £1.66). At £1.18, the stock trades 13% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Target Healthcare REIT a 54% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between £1.15 and £1.22; in 9 out of 10, between £1.09 and £1.29. Estimated annual volatility is 16%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Target Healthcare REIT sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks THRL.LSE has traded between £0.920 and £1.18. Today it is at its high and 28% above its low.
On the business: net margin is 104.4%; it trades at 8.8 times earnings.
Its beta is 0.55: it tends to move less than the market.
Target Healthcare REIT PLC is an externally managed FTSE 250 Real Estate Investment Trust. The firm provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes.
Want to see everything about Target Healthcare REIT?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About £1.35 per share according to ATLAS (reasonable range: £0.763 to £1.66). With the stock at £1.18, it is 13% below it.
54%: close to a coin flip. In half of the simulated outcomes, THRL.LSE ends the month between £1.15 and £1.22.
Target Healthcare REIT's market capitalization is £714M. Its price-to-earnings (P/E) ratio is 8.8: you pay £8.80 for each £1.00 of yearly earnings.
Yes. THRL.LSE's current dividend yield is 5.24% at today's price (£1.18).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy